通波仔如何改善冠心病？－ 鄧勁勳心臟科專科醫生@FindDoc.com

通波仔如何改善冠心病？－ 鄧勁勳心臟科專科醫生@FindDoc.com
FindDoc Facebook : / finddoc
FindDoc WeChat : 快徳健康香港 FindDoc
FindDoc Instagram：@finddochk
（一）膽固醇過高是冠心病元兇？ 00:06
（二）通波仔如何改善冠心病？ 00:36
（三）通波仔後還需控制膽固醇嘛？ 01:34
（本短片作健康教育之用，並不可取代任何醫療診斷或治療。治療成效因人而異，如有疑問，請向專業醫療人士諮詢。)
參考資料：
1. World Health Organization. (2011). Global status report on noncommunicable diseases 2010. Retrieved October 5, 2021, from www.who.int/nm...
2. 智對膽固醇 - centre for health protection. (2011). Retrieved October 25, 2021, from www.chp.gov.hk....
3. 醫院管理局. (2021). 智友站-冠心病. Retrieved October 5, 2021, www21.ha.org.h...
4. 醫院管理局. (2016). 冠狀動脈介入治療術. www.ekg.org.hk....
5. Hochman, J. S., Lamas, G. A., Buller, C. E., Dzavik, V., Reynolds, H. R., Abramsky, S. J., ... & Knatterud, G. L. (2006). Coronary intervention for persistent occlusion after myocardial infarction. New England Journal of Medicine, 355(23), 2395-2407.
6. Department of Health. (n.d.). Oral cholesterol lowering drugs. Retrieved October 25, 2021, from www.drugoffice...
7. Zhang, Z. J., Marroquin, O. C., Weissfeld, J. L., Stone, R. A., Mulukutla, S. R., Williams, D. O., Selzer, F., & Kip, K. E. (2009). Beneficial effects of statins after percutaneous coronary intervention. European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology, 16(4), 445-450. doi.org/10.109...
8. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J 2019; 41(1): 111-88.
資料來源：www.FindDoc.com
查詢醫生資訊：www.finddoc.com/